Budget Impact on the Use of Pegfilgrastim to Reduce the Febrile Neutropenia During Chemotherapy for Breast Cancer with Moderate Risk Compared to a Standard Therapy
Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.2212
https://www.valueinhealthjournal.com/article/S1098-3015(14)04142-4/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1672
First Page :
A623
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04142-4&doi=10.1016/j.jval.2014.08.2212